Featured Investigator: Scout, MA, PhD
August 2022: Scout, MA, PhD Scout is the Executive Director of the National LGBT Cancer Network and the principal investigator of both the CDC-funded LGBTQ tobacco-related cancer disparity network and Out: The National Cancer Survey. He spends much of his time providing technical assistance for tobacco and cancer focusing agencies expanding their reach and engagement with LGBTQ+ populations. Scout has a long history in health policy analysis and a particular interest in expanding LGBTQ+ surveillance and research. He has faculty appointments at both Brown University and Boston Universities’ Schools of Public Health. He is a member of the NIH Council of Councils, the Co-Chair of the NIH Sexual and Gender Minority Research Office Work Group, on the Advisory Panel for NIH’s All of Us initiative, and a U.S. Pharmacopeial Convention delegate. His work has won him recognition from the U.S. House of Representatives, two state governments, and many city governments. Scout is an openly transgender father of three, a vegetarian, an avid hiker, and runner. |
Q: What are your current research interests? |
Q: Tell us about your career path – how did you end up where you are now? When I graduated I was one of two openly trans PhD level health researchers I knew, which is a lonely place to be. But Judy continued helping me land well, pulling me into one of the biggest SGM health centers in the country to be the head of trans research. But to be honest, while she was a staunch ally, the rest of the environment was at times quite chilly. Nonetheless I continued stepping ahead, doing a large national tobacco study and building my connections as Judy pulled me into more and more national queer health planning efforts. Soon I was the Science Director for the National LGBT Health Coalition and meeting with heads of different HHS OpDivs to get community health priorities moving. A key thing this work taught me was how policy shapes the ability of researchers to be able to conduct good SGM science. For many years, the researchers around me had to use coded words to get NIH studies about queers funded. They endured a brisk change of political winds everytime the President changed. They had to deal with their lives and or research being mocked by right wing trolls, including one time when there was a full scale witchhunt of queer researchers that to be honest, drove many away from the field. Because of this persistent headwind, I leaned into policy more and more, including pushing HHS’s Office of Minority Health to include SGM issues in cultural competency standards, a multi-year push to get SGM acknowledged as a health disparity population by NIH, then another to get an office of SGM health opened at NIH.
Ultimately all those things were achieved, which makes me very proud. But I continue to push on what is now my longest term professional goal, getting enough SGM data for us to write compelling needs statements for our research project. Our communities data gaps have too often left us unable to be as competitive as researchers in other topics, and with highly competitive paylines this is one of the biggest barriers to getting more SGM research. En route to this goal, I’ve continued to speak up about the needs of our research community frequently.
For most of this time, I was funded primarily by CDC to run a tobacco and cancer disparity network but since we don’t get public health interventions without identifying problems via data, then researching what interventions work, I’ve continued to focus on opened that research pipeline wider. I worked with a few amazing students to publish the first analysis of NIH funding, a process that’s now become an annual activity of the SGMRO. I continued to listen to my research colleagues about what was slowing them down and speaking up about it to NIH leadership. While the head of NIH didn’t answer many of my early letters, eventually he started to meet with me and others we would assemble; by the time he retired I had been pulled in to many official advisory committess and we were on first name basis, as I still am with the current Interim Director. I am now ending my term as a member of the Council of Councils and as Co-Chair of the SGMRO Work Group. I am still on the advisory committee for what I admit is probably my favorite study, All of Us. I like to think of All of Us as research 2.0, where underrepresented people make up a majority of the study population and diversity is seen as a strength of the data collected.
Meanwhile on the career side, except for a two year gap I’ve now run the CDC funded tobacco and cancer disparity network for over a dozen years. I love how that work lets me provide technical assistance to states and federal entities looking to do better work on SGM health. For the last few years I’ve now moved into being the Executive Director of the National LGBT Cancer Network. I love the team we’ve assembled to do that work, and I find it interesting to learn about industry (i.e. pharmaceutical) options for getting research funded. My most recent research project is Out: The National Cancer Survey, where we had 2,700 queer cancer survivors tell us about what worked and what went wrong. Now that dataset is available for researchers to use and at least a dozen nationwide are doing different types of secondary analyses. What’s next for me on the research front? Two things: I want to run a similar study of cancer caregivers and we’ve started a new mentorship program, Cancer Leaders Like Us, which I hope can help pave the way to get more queer and minoritized researchers into the field. The other day I gave a career talk to an NIH group of fellows, and as I started one of the participants admitted they were almost crying, simply because they don’t see senior people like me in the field very much. So I’m reminded on a very frequent basis how lucky I am to have come so far, and the responsibility that confers to do my level best to clear the path for other unrecognized and undervalued people to follow. |
Q: What organizational challenges have you faced? |
Q: What advice do you have for trainees and researchers who want to work in this area or are interested in applying for NIH funding? |
Q: Do you have any specific advice for working with and involving SGM populations in research? |
Q: Who inspires you? |
Q: Any final words of wisdom? |